Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1975 2
1976 2
1977 1
1979 1
1980 2
1981 5
1982 8
1983 14
1984 18
1985 24
1986 27
1987 14
1988 24
1989 13
1990 8
1991 12
1992 8
1993 10
1994 3
1995 4
1996 7
1997 3
1998 4
1999 4
2000 2
2002 4
2003 4
2004 3
2005 5
2006 5
2007 4
2008 7
2009 8
2010 10
2011 5
2012 5
2013 2
2014 3
2015 6
2016 2
2017 10
2019 2
2020 2
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Results by year

Filters applied: . Clear all
Page 1
Insulin analogues in pregnancy and specific congenital anomalies: a literature review.
de Jong J, Garne E, Wender-Ozegowska E, Morgan M, de Jong-van den Berg LT, Wang H. de Jong J, et al. Diabetes Metab Res Rev. 2016 May;32(4):366-75. doi: 10.1002/dmrr.2730. Epub 2015 Nov 6. Diabetes Metab Res Rev. 2016. PMID: 26431249 Review.
Of 29 studies, we included 1286 foetuses of mothers using short-acting insulin analogues with 1089 references of mothers using human insulin and 768 foetuses of mothers using long-acting insulin analogues with 685 references of mothers using long-acting human insulin (N …
Of 29 studies, we included 1286 foetuses of mothers using short-acting insulin analogues with 1089 references of mothers using human insulin …
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience.
Chan WB, Chen JF, Goh SY, Vu TTH, Isip-Tan IT, Mudjanarko SW, Bajpai S, Mabunay MA, Bunnag P. Chan WB, et al. Diabetes Metab Syndr Obes. 2017 Dec 15;10:521-532. doi: 10.2147/DMSO.S143046. eCollection 2017. Diabetes Metab Syndr Obes. 2017. PMID: 29276400 Free PMC article. Review.
Significant progress has been made with long-acting insulin analogs (insulin glargine 100 units/mL and insulin detemir), which provide longer coverage and less risk of hypoglycemia over intermediate-acting insulin (Neutral Protamine Hagedorn insulin). Furthermore, r …
Significant progress has been made with long-acting insulin analogs (insulin glargine 100 units/mL and insulin detemir), which provide longe …
Clinical pharmacology of human insulin.
Heinemann L, Richter B. Heinemann L, et al. Diabetes Care. 1993 Dec;16 Suppl 3:90-100. doi: 10.2337/diacare.16.3.90. Diabetes Care. 1993. PMID: 8299482 Review.
Cardiovascular effects of basal insulins.
Mannucci E, Giannini S, Dicembrini I. Mannucci E, et al. Drug Healthc Patient Saf. 2015 Jul 10;7:113-20. doi: 10.2147/DHPS.S43300. eCollection 2015. Drug Healthc Patient Saf. 2015. PMID: 26203281 Free PMC article. Review.
The aim of this review is to provide an overview of the potential cardiovascular safety of the different available preparations of basal insulin. Current basal insulin (neutral protamine Hagedorn [NPH], or isophane) and basal insulin analogs (glargine, detemir, and …
The aim of this review is to provide an overview of the potential cardiovascular safety of the different available preparations of basal ins …
Advances in pharmacological treatment of type 1 diabetes during pregnancy.
Patti AM, Giglio RV, Pafili K, Rizzo M, Papanas N. Patti AM, et al. Expert Opin Pharmacother. 2019 Jun;20(8):983-989. doi: 10.1080/14656566.2019.1593372. Epub 2019 Mar 29. Expert Opin Pharmacother. 2019. PMID: 30924387 Review.
Strict control of pre- and post-prandial glucose is also required. Human soluble insulin, neutral protamine Hagedorn and the quick-acting insulin analogues aspart and lispro are widely used. ...
Strict control of pre- and post-prandial glucose is also required. Human soluble insulin, neutral protamine Hagedorn and the q …
Insulin analogues: new dimension of management of diabetes mellitus.
Siddiqui NI. Siddiqui NI. Mymensingh Med J. 2007 Jan;16(1):117-21. doi: 10.3329/mmj.v16i1.266. Mymensingh Med J. 2007. PMID: 17344794 Review.
It is almost impossible to mimic the endogenous physiological insulin secretion curve by external administration of short acting human insulin and conventional intermediate acting insulin, neutral protamin Hagedorn (NPH), the so called basal insulin. ...
It is almost impossible to mimic the endogenous physiological insulin secretion curve by external administration of short acting human insul …
Third-line Drugs for Type 2 Diabetes — Project Protocol [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Aug 22. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Aug 22. PMID: 30234937 Free Books & Documents. Review.
Meglitinides and alpha-glucosidase inhibitors, however, did not. The addition of insulin neutral protamine Hagedorn (NPH) to metformin plus a sulfonylurea was associated with the most favourable cost-effectiveness estimates. ...
Meglitinides and alpha-glucosidase inhibitors, however, did not. The addition of insulin neutral protamine Hagedorn (NPH) to m …
Insulin lispro: a review of its use in the management of diabetes mellitus.
Simpson D, McCormack PL, Keating GM, Lyseng-Williamson KA. Simpson D, et al. Drugs. 2007;67(3):407-34. doi: 10.2165/00003495-200767030-00006. Drugs. 2007. PMID: 17335298 Review.
Insulin lispro alone, or as a premixture with the longer-acting insulin neutral protamine lispro, can be administered immediately before or after meals. ...
Insulin lispro alone, or as a premixture with the longer-acting insulin neutral protamine lispro, can be administered immediat …
306 results